CAG trinucleotide polymorphisms in the neuronal small conductance calcium-activated potassium channel gene hKCa3 have been reported to be associated with schizophrenia. Attempts to confirm this finding have met with mixed results. We investigated hKCa3 CAG allele lengths in families from the National Institute of Mental Health (NIMH) Schizophrenia Genetics Initiative, by comparing transmission to discordant siblings and parental transmission to affected offspring. Overall, there was no convincing evidence that hKCa3 CAG lengths differ between schizophrenics and controls. We did, however, observe a trend (P = 0.063) toward over-representation of long (Ն19) CAG repeats in the shorter of the two hKCa3 alleles in schizophrenics. There was no evidence of excessive parental transmission of long CAG repeat alleles to affected offspring. In addition, we re-mapped hKCa3 and found that it resides on chromosome 1q21, in a region which has been linked to familial hemiplegic migraine, but not to schizophrenia. These data provide no significant support for the association of hKCa3 with schizophrenia.
Since the initial report, 7 six other studies have examined the association of hKCa3 with schizophrenia in case-control, 8, 10 or family-based [11] [12] [13] [14] studies. Of these, two 8, 10 (both case-control studies) found support for an association of longer repeat length alleles with schizophrenia, three 11, 13, 14 found no support, and one 12 found a marginally significant association of short (Յ19) repeat alleles with schizophrenia. Only further studies in other populations will determine whether the association is limited to subpopulations of schizophrenic patients, or is a statistical artifact.
As the initial conceptual association of hKCa3 to schizophrenia was due to chromosomal localization of hKCa3 to a schizophrenia locus, it was important to determine its map location, particularly because others have mapped the gene to chromosome 1. 11 We performed radiation hybrid mapping using the GeneBridge 4 panel. 15 Two independent primer sets were used, PCR reactions were repeated twice for each set, and parameters were varied in multiple ways on submission of results for mapping. In all cases, results indicated that hKCa3 maps to chromosome 1q21, between markers D1S305 and IB1251, 2.63 cR from D1S305. This finding was confirmed by hybridization. hKCa3 therefore resides on 1q21, not in the 22q11-13 schizophrenia susceptibility locus 6 as initially reported. 5 The 1q21 region has been linked to familial hemiplegic migraine 16, 17 but not to schizophrenia or any other neuropsychiatric disorder, 18, 19 though variations in heterochromatin in the 1q21 region have been reported in schizophrenics. 20 Independent of the gene's map location, the observation of association between longer-CAG hKCa3 repeat alleles and schizophrenia was important, so we investigated hKCa3 repeat lengths in the population of the National Insitute of Mental Health (NIHM) Schizophrenia Genetics Initiative. This dataset is made up of extended families, with members both affected and unaffected with schizophrenia. Diagnostic assessment in the NIMH collection was done using the Diagnostic Interview for Genetic Studies (DIGS). 21 Genomic DNA samples were obtained from all individuals in the database who had a Best Estimation of Lifetime Psychiatric Diagnosis of schizophrenia (SZ) (DSM-IIIR diagnostic code 295.1x, 295.2x, 295.3x 295.6x, or 295.9x), and from all available relatives who had never been mentally ill (NMI). The SZ subjects were generally younger and more likely to be male than the NMI controls (Table 1) .
A total of 240 DNA samples, 187 from schizophrenic SZ  186  19  77  37  109  77  0  NMI  54  16  86  55  19  34  1  Total  240  16  86  38  128 111  1 individuals and 53 from NMI control family members, were genotyped for hKCa3 CAG repeat lengths. hKCa3 has two distinct CAG repeat regions at its 5Ј end, 7 and each was assayed separately by PCR. Virtually no polymorphism was found in the first repeat: of 480 alleles, 479 had 12 CAGs, and one had 13 CAGs. This lack of variability is in agreement with a previous study. 7 The second CAG repeat was highly polymorphic, with repeat number ranging from 12-23. Although the NIMH Schizophrenia Genetics Initiative dataset contained almost 90 families, only 37 of these had DNA samples available on both SZ and NMI subjects. The structures of these families were irregular and sometimes complex. For analysis we used 20 sibships to compare transmission to discordant siblings. For the analysis of parental transmission, we identified 47 informative parental transmissions to affected offspring. The statistical analyses focused on linkage of hKCa3 to schizophrenia in the presence of association, using tests similar to the sibling transmission disequilibrium test (STDT) 22 and the transmission disequilibrium test (TDT). 23 Note that although we view these as tests of linkage, we recognize that the tests have no power in the absence of association between CAG repeat length and schizophrenia.
For the sibships, both an analysis using CAG repeat length and an analysis dichotomizing these lengths based on the mode of the distribution 7, 8, 10, 12 were performed. The former analysis compares the middle of the CAG repeat distribution between schizophrenics and their NMI sibling controls, while the latter analysis compares only the upper tail; P-values reported are one-sided. Since each individual has two hKCa3 alleles, spearate analyses were performed using the value of the longer CAG repeat allele, the shorter CAG repeat allele, the sum of CAG repeats in both alleles, and the absolute difference in the number of CAG repeats in the two alleles. For each analysis, data from uninformative sibships (ie, sibships in which the number of CAG repeats was the same in all SZ and NMI siblings), were excluded, since these sibships provided no linkage information.
Comparison of the center of distribution of CAG repeat lengths, as well as separate analyses of shorter and longer alleles (60/64 siblings were heterozygous for CAG repeat length), showed no difference in overall allele frequencies between SZ and NMI subjects ( Table  2 and Figure 1 ). Three previous reports 7, 8, 10 similarly found that overall hKCa3 CAG repeat distribution did not differ between schizophrenics and controls, but each also found that there was a significant overrepresentation of repeat numbers above the mode in the schizophrenic subjects. We performed an analysis using a similar dichotomization (Table 3) . In this analysis, the prevalence of CAG repeats greater than the mode in the short CAG repeat length allele was greater in schizophrenics than in controls, though this difference did not reach statistical significance (P = 0.063). In the four families with informative data on the short CAG repeat length allele, 4/5 schizophrenic subjects, and 0/5 NMI subjects, had CAG repeat numbers above the mode of 18. Similar analysis of the long, sum, and difference between alleles after dichotomization at the mode did not demonstrate any differences between schizophrenics and controls ( Table 3) . Next, we examined parental transmission of hKCa3 CAG repeat alleles to their schizophrenic offspring (Table 4 ). There were seventy-one SZ offspring for which we had information on at least one parent. Homozygous parents and cases where transmission could not be deduced from available genotypes were excluded leaving 47 informative parental transmissions. A permutation test on the transmitted allele from heterozygous parents gave no evidence that parents transmitted the allele with the longer CAG repeat length more often than the allele with the shorter CAG repeat length to schizophrenic offspring (P = 0.96). Note that as per the results of Curtis and Sham 24 this test was expected to have a slightly inflated false positive rate, but despite this no excess parental transmission was observed.
In summary, we obtained little support for an association between schizophrenia and hKCa3 CAG repeat length. We did observe a trend toward excess transmission to schizophrenics of short CAG alleles with repeat lengths above the mode. However, this finding did not reach statistical significance, and could easily be an artifact of sampling and multiple testing.
The limitations of this study are the relatively small sample size and its heterogeneity. Though the total number of alleles analyzed (480) was large, the number usable for each analysis was smaller, given the family requirements of the tests used. 3 The NIMH population studied is an ethnically and racially heterogeneous American population, in which detection of susceptibility genes for complex multigenic diseases like schizophrenia is more difficult. 25 Several of the seven previous studies on the relation of hKCa3 CAG lengths to schizophrenia have used more homogeneous populations: French/Alsatian, 7 Anglo-Saxon, 8 Israeli Jewish, 10 Chinese, 11 and Irish; 13 three have produced positive results of association, and two negative.
The initial studies which reported association of hKCa3 with schizophrenia utilized designs where cases were compared to independent controls. Though this design may be quite powerful for detecting susceptibility genes for complex disorders such as schizophrenia, 25 it may produce spurious results as it cannot distinguish between association due to factors such as stratification and admixture, and association due to linkage. The more robust family-based analyses used here and in other recent negative studies [11] [12] [13] [14] ameliorate these stratification limitations by using family members as controls. Given that the only positive results associating hKCa3 with schizophrenia have come from case-control studies, it is possible that these results are false-positives reflecting nonrandom stratification.
In light of the significant pathophysiologic and therapeutic importance a verification of hKCa3 association with schizophrenia would have, and in light of the absence of such verification by several studies, the rationale for the original hypothesis merits re-examination. The connection was made because of two initial findings: first, that hKCa3 mapped to a chromosomal locus linked to schizophrenia, and second, that hKCa3 has a polymorphic CAG repeat which was larger in some schizophrenics. Expansion of CAG repeats is responsible for several other brain diseases, and anonymous expansions have been found in schizophrenics, so such an association of larger hKCa3 CAG numbers to schizophrenia was attractive.
Evidence accumulated since the original report 7 calls into question these initial reasons for hKCa3 being designated a schizophrenia candidate gene. First, remapping has shown that hKCa3 does not map to the schizophrenia locus initially hypothesized. Second, the majority of genetic studies of hKCa3 CAG repeat polymorphisms in schizophrenia have shown no evidence of association or linkage. Third, though one of the CAG repeats in hKCa3 is indeed polymorphic, in no study have expansions been found that would account for the overabundance of CAG repeats found in schizophrenic populations by the RED method. 3 Thus, the aggregate data to date appear to argue against a role for hKCa3 in most schizophrenia cases, though it remains possible that hKCa3 polymorphisms may confer schizophrenia risk on certain genetic backgrounds. It is of interest, for example, that Shamir et al 10 found in Israeli Jews that hKCa3 short alleles with CAG number greater than the mode were associated with a particular subtype of schizophrenia, consistent with our finding of a trend in this direction in the NIMH schiozphrenia population. In contrast, Stober et al 12 reported in their study that schizophrenia was associated with CAG lengths shorter than the mode (Յ 19 repeats).
The mechanism by which hKCa3 polymorphism might confer susceptibility to schizophrenia would presumably be different from the gain of toxic function mechanism hypothesized for the CAG repeat/ polyglutamine expansion disorders such as Huntington's disease or the spinocerebellar ataxias. 26 The latter are neurodegenerative disorders characterized by cell death of particular populations of CNS neurons; consistent neuropathology has not been found in the brains of schizophrenics. 27 A more appropriate mechanistic analogy may be the small polyglutamine number variations in the calcium channel ␣1a subunit, encoded by CAG expansions in CACNA1A, which are thought to cause Episodic Ataxia Type 2 (EA-2) by a loss of channel function mechanism. 28 Given the recent linkage of familial hemiplegic migraine (FHM) to the region of chromosome 1q21 to which hKCa3 maps, 16, 17 it will be important to examine hKCa3 CAG polymorphism in these populations of FHM patients, to assess whether polyglutamine polymorphism or other mutation in hKCa3 might be associated with FHM. Intriguingly, mutation in CACNA1A may cause FHM, EA-2, or spinocerebellar ataxia type 6, depending on the nature of the mutation. [28] [29] [30] Resolution of the question of hKCa3's role in schizophrenia will require genotyping of larger collections of families to determine linkage of hKCa3 to schizophrenia and association of CAG repeat expansions with disease. Ultimately, demonstration of a biophysical change in hKCa3 channel function upon change in glutamine number, and evaluation of behavioral abnormalities in animals transgenic for these constructs, will be essential to settle whether the observed polymorphism in the hKCa3 CAG repeat is pathogenic or benign.
Methods

Subjects
Data were obtained from a database collected and maintained by the National Institute of Mental Health (NIMH, Bethesda, MD, USA) Genetics Initiative. This database contains information on families ascertained by Colombia University, Harvard University, and Washington University. Genomic DNA samples were obtained for all individuals in the database from whom a blood sample was drawn and who also had a best estimation of lifetime psychiatric diagnosis of schizophrenia (SZ) (DSM-IIIR diagnostic code 295.1x, 295.2x, 295.3x, 295.6x, or 295.9x), and from all their available relatives who had never been mentally ill (NMI). Demographic characteristics for all individuals sampled are in Table 1 . Family structures for the sampled individuals were irregular and sometimes complex. For the sib analysis, we identified 20 sibships having at least one SZ and at least one NMI. In total these 20 sibships had 31 SZs and 23 NMIs. For the analysis of parental transmission, we identified 47 informative parental transmissions to SZ offspring.
Genotyping
Each of the two CAG repeats was amplified separately from genomic DNA by PCR. Primers were: CAG repeat one: 5Ј-CAGCAGCCCCTGGGACCCTCGC-3Ј (forward) and 5Ј-GGAGTTGGGCGAGCTGAGACAG-3Ј (reverse), and CAG repeat two: 5Ј-CAAGTGCCCCTGTCCAT CCTC-3Ј (forward) and 5Ј-GCGAGGGTCCCAGGGGC TGCTG-3Ј (reverse). PCR amplification was performed in the presence of [␣-
35 S] dATP, followed by denaturing polyacrylamide gel electrophoresis and autoradiography. PCR conditions were: 94°C for 1 min, 32 cycles of 94°C for 20 s and 68°C for 2 min, then 68°C for 5 min, using Advantage-GC Genomic PCR (Clontech, Palo Alto, CA, USA). An M13 sequence ladder was used as size standard to quantify CAG repeat number. Repeat number was confirmed by direct sequencing in 49 of the 240 samples.
Sib analysis
An analysis of siblings compared the number of CAG repeats in SZ subjects with their NMI siblings. Linkage was tested using methods similar to the sibling transmission disequilibrium test 22 and the transmission dis-equilibrium test. 23 Eight genotypic scores were calculated for each sibling: four allele lengths (length of long allele, length of short allele, sum of allele lengths, absolute difference of allele lengths) and four dichotomous variables where a score of 0 or 1 was assigned based on the following conditions: long allele Յ 19, short allele Յ 18, sum of alleles Յ 35, and difference of alleles = 0. Each of these eight genotypic scores was analyzed separately using a permutation test. For a particular score, the test statistic was the sum of that score over all NMI siblings. The observed value of the test statistic was compared to the distribution of the test statistic over all possible permutations of the SZ and NMI labels that maintain the observed number of SZ and NMI siblings in each sibship. The P-values reported give the proportion of these permutations that give a value of the test statistic that is less than or equal to the observed value of the test statistic. Note that for each analysis, data from uninformative sibships, namely sibships for which the summary measure of CAG repeat number was the same for SZ and NMI members, were excluded.
Analysis of parental transmission
Parental transmission was analyzed using the subset of the data for which CAG repeat lengths were available for at least one parent and at least one affected offspring. The test statistic was the difference between the number of parental transmissions of the allele with the longer CAG repeat length and the allele with the shorter CAG repeat length to affected offspring. In almost all cases only the maternal genotype was available. The one-side P-value was calculated using the exact permutation distribution of the test statistic.
Chromosomal localization
Mapping of hKCa3 was performed using the GeneBridge 4 panel, 15 consisting of 93 radiation hybrid clones (Research Genetics, Huntsville, AL, USA). Two primer pairs were designed from the published hKCa3 sequence to amplify each of two different regions of the gene. Primer pair 1 had sequences: 5Ј-GACTTGGATGAAGACCCCAAGTG-3Ј (forward) and 5Ј-GAAGCGGTGGGAGAGGAGTGCAG-3Ј
(reverse) and produced the expected band of ෂ300 bp. Primer pair 2 had sequences: 5Ј-CAGCA GCCCCTGG GACCCTCGC-3Ј
(forward) and 5Ј-GGAGTT GGGCGAGC TGAGACAG-3Ј (reverse) and produced the expected band of ෂ150 bp. Advantage-GC genomic PCR (Clontech) was peformed with cycling parameters: 94°C for 1 min; 94°C for 20 s, 68°C for 2 min, 32 cycles; 68°C for 5 min. Results for each primer pair were submitted separately to the Whitehead Institute Genome Center server (http://www.genome.wi.mit.edu/cgibin/contig/rhmapper.pl), and gave similar results.
